IRIS
metadata only
Esophageal Function Testing Identifies Barrett’s Esophagus Patients With Pathological Acid Exposure at Risk for Neoplasia
Background & Aims Pathological esophageal acid exposure may persist in patients with Barrett’s esophagus (BE), despite proton pump inhibitor (PPI) administration and symptom control. We aimed to determine the role of esophageal function testing in assessing acid exposure in patients with BE on P
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus#903253
- Obeticholic Acid for Prevention in Barrett's Esophagus#834752
- Detection of Barrett s Esophagus in Patients Without GERD Symptoms#1125530
- Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus#828182
- Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)#871928
Record · ID 988050
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive